Business · 02/04/2019

FDA to Hold Public Meeting on Limited Population Pathway for Antibacterial and Antifungal Drugs

The US Food and Drug Administration (FDA) is hosting a public meeting to gather comments on a draft guidance for a limited population pathway for antibiotics and antifungals, which was first published in 2018 and is now open for additional feedback.